Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Human GST P1-1 Redesigned for Enhanced Catalytic Activity with the Anticancer Prodrug Telcyta and Improved Thermostability
Stockholm University, Faculty of Science, Department of Biochemistry and Biophysics.ORCID iD: 0000-0001-9048-0893
Stockholm University, Faculty of Science, Department of Biochemistry and Biophysics. Scripps Research, USA.ORCID iD: 0000-0002-6416-064x
Number of Authors: 32024 (English)In: Cancers, ISSN 2072-6694, Vol. 16, no 4, article id 762Article in journal (Refereed) Published
Abstract [en]

Protein engineering can be used to tailor enzymes for medical purposes, including antibody-directed enzyme prodrug therapy (ADEPT), which can act as a tumor-targeted alternative to conventional chemotherapy for cancer. In ADEPT, the antibody serves as a vector, delivering a drug-activating enzyme selectively to the tumor site. Glutathione transferases (GSTs) are a family of naturally occurring detoxication enzymes, and the finding that some of them are overexpressed in tumors has been exploited to develop GST-activated prodrugs. The prodrug Telcyta is activated by GST P1-1, which is the GST most commonly elevated in cancer cells, implying that tumors overexpressing GST P1-1 should be particularly vulnerable to Telcyta. Promising antitumor activity has been noted in clinical trials, but the wildtype enzyme has modest activity with Telcyta, and further functional improvement would enhance its usefulness for ADEPT. We utilized protein engineering to construct human GST P1-1 gene variants in the search for enzymes with enhanced activity with Telcyta. The variant Y109H displayed a 2.9-fold higher enzyme activity compared to the wild-type GST P1-1. However, increased catalytic potency was accompanied by decreased thermal stability of the Y109H enzyme, losing 99% of its activity in 8 min at 50 °C. Thermal stability was restored by four additional mutations simultaneously introduced without loss of the enhanced activity with Telcyta. The mutation Q85R was identified as an important contributor to the regained thermostability. These results represent a first step towards a functional ADEPT application for Telcyta.

Place, publisher, year, edition, pages
2024. Vol. 16, no 4, article id 762
Keywords [en]
glutathione transferase P1-1, ADEPT, Telcyta, canfosfamide, protein engineering, machine learning, molecular redesign, prodrugs, thermostability
National Category
Biochemistry Molecular Biology
Identifiers
URN: urn:nbn:se:su:diva-227812DOI: 10.3390/cancers16040762ISI: 001172261500001PubMedID: 38398153Scopus ID: 2-s2.0-85185945928OAI: oai:DiVA.org:su-227812DiVA, id: diva2:1847112
Available from: 2024-03-26 Created: 2024-03-26 Last updated: 2025-03-11Bibliographically approved
In thesis
1. A study of Pi- and Alpha-class glutathione transferases: Characterization and protein redesign for medical applications
Open this publication in new window or tab >>A study of Pi- and Alpha-class glutathione transferases: Characterization and protein redesign for medical applications
2025 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Glutathione transferases (GSTs) are a family of enzymes that are key players in cellular detoxication. These enzymes catalyze the transfer of glutathione (GSH) to the electrophilic center of harmful compounds to promote their elimination.

The human Pi class (GST P1-1) is well-known for its overexpression in cancerous tissue and has been found to contribute to tumor growth and chemotherapeutic resistance. For these reasons, GST P1-1 has emerged as a promising therapeutic target to fight cancer by developing inhibitors and prodrugs (e.g. Telcyta) targeting the enzyme. GST P1-1 has also been suggested as a marker during carcinogenesis.

Apart from being cellular detoxicants some GSTs have come to develop other functions. One member of the human Alpha class, GST A3-3, plays an important role in steroid hormone biosynthesis by catalyzing the double-bond isomerization reaction of 5-androsten-3,17-dione and 5-pregnen-3,20-dione, precursors to the steroid hormones testosterone and progesterone. To date, in addition to the human enzyme, efficient ketosteroid isomerase activity has been identified in Alpha-class enzymes from equine and porcine tissues.

This thesis focuses on studying the Pi- and Alpha-class enzymes. In the first study, we characterize dog GST P1-1 and show that the enzyme shares certain class-specific similarities with the human enzyme in terms of substrate selectivity profile and inhibition profile. We also developed a thin-layer chromatography method to screen and semi-quantify Telcyta activity. In the second study, we show that the replacement of tyrosine109 with histidine increased the activity with the anticancer prodrug Telcyta 2.9-fold, and we also show that the mutation Q85R positively influenced the thermostability of the enzyme. In the third study, we discovered a mutant enzyme, V2 (Q40M-E41Q-A46S-Y109H-V200L), with 22-fold higher catalytic efficiency than wildtype human GST P1-1 with cumene hydroperoxide. The mutation Y109H was responsible for a 10-fold increase in catalytic efficiency. In the fourth study, we discovered that GST A3-3 from the common marmoset monkey possessed prominent ketosteroid isomerase activity, albeit significantly lower than its human and equine counterparts, it was on par with porcine GST A2-2. In the fifth study, we solved the crystal structure of equine GST A3-3 in complex with the inhibitor triethyltin bromide. The structure reveals the interaction between triethyltin bromide, GSH, and Tyr9 in the enzyme.

All in all, the work presented in this thesis has added to the body of knowledge on the glutathione transferases from the Pi- and Alpha-classes.

 

Place, publisher, year, edition, pages
Stockholm: Department of Biochemistry and Biophysics, Stockholm University, 2025. p. 52
Keywords
Glutathione transferases, GST A3-3, steroidogenesis, GST P1-1, cancer, Telcyta, enzyme inhibiton, ADEPT, protein engineering
National Category
Chemical Sciences Biochemistry
Research subject
Biochemistry
Identifiers
urn:nbn:se:su:diva-240646 (URN)978-91-8107-156-6 (ISBN)978-91-8107-157-3 (ISBN)
Public defence
2025-05-19, C458, Kemiska övningslaboratoriet, Svante Arrhenius väg 16 C and online via Zoom, public link is available at the department website, Stockholm, 13:00 (English)
Opponent
Supervisors
Available from: 2025-04-24 Created: 2025-03-11 Last updated: 2025-04-08Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Ismail, AramMannervik, Bengt

Search in DiVA

By author/editor
Ismail, AramMannervik, Bengt
By organisation
Department of Biochemistry and Biophysics
In the same journal
Cancers
BiochemistryMolecular Biology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 51 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf